Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024
Months
January February March April May June July August September October November December
Previous Archive
19 February 2018

Khomotso matriculated in Lephalale in Limpopo and made her way to Bloemfontein in January 2014. She was determined to succeed in life and knew that she had one chance to achieve her objective, which was to obtain a degree. However, coming from a family with an annual income of less than R80 000 she knew she would have to find funding. She secured a bursary with Distell, although it would only cover her tuition, so her next challenge was finding funding for meals and other expenses.

Making a difference daily
When she arrived at the University of Free State (UFS) she applied for the No Student Hungry (NSH) Food Bursary through the Social Work Services office and was successful. The weekly NSH funds she received enabled her to buy food and offered her extra opportunities to develop herself through student wellness workshops. NSH funded her for the next three years. “It was a relief not to worry about where my next meal would come from, allowing me time to concentrate on my studies,” said Khomotso.

Three years later she graduated with 22 distinctions and is pursuing her postgraduate studies in Education in 2018. For her, it is important to create the change that our country needs. “It was my teachers and parents who inspired me to pursue a degree. As a future teacher, I want to be able to make a difference in the lives of young people. “

Donors key in reducing food insecurity
Like Khomotso, there are many academically strong students who lack adequate financial support to sustain them through their degree programmes. For this reason, the financial contributions made to the NSH Food Bursary Programme by staff of the UFS, alumni and other donors remains crucial. Systemic change occurs when students graduate and join the country’s workforce. Together, we continue to cause ripples of change in our country.

The South African Surveys of Student Engagement Annual Report (2016) reflects that “it is clear that financial stress impacts on different areas of students’ lives. It is also clear that the impact is magnified for those who are already vulnerable, such as students who come from poor families”.

No Student Hungry supports students on their journey to success

Figure 7 shows that 32% of black African students reported that they ran out of food and could not afford to buy more on most days or every day. Similarly, a significant difference in responses is seen between first- and non-first-generation students, with 77% of first-generation students indicating that they ran out of food without being able to buy more, compared to 53% of non-first-generation students.

The overall academic average of 2017 NSH students was 61% on all three UFS campuses, with the top 10 achievers of 2017 being females predominantly in the black African and coloured designated groups, in the fields of Communication, Law, Education, Science, Social Science and Psychology, scoring on average above 70%.

Give to the NSH Food Bursary.

Contact: Vicky Simpson, Officer Institutional Advancement SimpsonVZ@ufs.ac.za /call: +27 51 401 7197.

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept